Quick Facts

Property Value
Category Telomerase-Regulating Peptide
Risk Level Experimental
Administration Subcutaneous Injection
Typical Frequency Nightly
Estimated Half-Life Short Plasma Half-Life / Long-Term Signaling Effects Discussed
Primary Research Interest Longevity / Cellular Aging / Recovery
Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and experimental longevity compounds. Epithalon is a biologically active peptide with limited large-scale human safety data and incompletely characterized long-term effects. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Reconstitution Guide

  • Vial Size: 50 mg
  • Dilutant Type: BAC Water
  • Amount of Dilutant Added: 5 mL
  • Final Concentration: 10.00 mg/mL

At this concentration:

• 10 mg = 1.000 mL (100.0 units)

• 20 mg = 2.000 mL (200.0 units)

2. Route of Administration

Epithalon is most commonly discussed as a subcutaneous injectable peptide compound.

  • Primary Route: SubQ Injection
  • Preferred Timing: Nighttime / before bedtime administration
  • Administration Notes: Longevity-oriented protocols commonly emphasize consistency during short cyclical runs rather than continuous year-round use

3. Typical Research Protocols

  • Product Strength: 10.00 mg/mL
  • Typical Delivered Amount: 10–20 mg before bedtime
  • Frequency: Every night before bed
  • Cycle Length: 30 days on / 5 months off, repeated biannually
  • Special Notes: Unlike peptides such as Somatropin or Tesamorelin, Epithalon is generally not discussed as a continuous year-round protocol. Most longevity-oriented discussions instead emphasize periodic cyclical use.

4. Summary

Epithalon is an experimental synthetic tetrapeptide originally researched for potential effects on cellular aging, melatonin regulation, telomerase activity, and longevity-associated signaling pathways.

Research interest in Epithalon primarily centers around anti-aging discussions, sleep regulation, recovery, and theoretical cellular lifespan support.

5. Mechanism of Action

Epithalon is believed to influence pineal gland signaling and telomerase-associated pathways involved in cellular aging and circadian regulation.

Potential downstream mechanisms discussed in research include:

  • Telomerase activation signaling
  • Circadian rhythm modulation
  • Melatonin regulation support
  • Cellular stress response modulation
  • Potential antioxidant pathway support

Much of the compound’s reputation within longevity communities stems from theoretical anti-aging mechanisms rather than extensive modern human clinical validation.

6. Potential Benefits

  • Potential sleep quality support
  • Improved circadian rhythm regulation
  • Theoretical longevity support
  • Potential recovery enhancement
  • Possible antioxidant signaling effects
  • Cellular stress response support

7. Potential Risks / Side Effects

Experimental

  • Limited long-term human safety data
  • Unknown effects on cellular growth signaling
  • Fatigue or lethargy
  • Headaches
  • Dizziness
  • Potential endocrine or circadian disruption
  • Theoretical cancer signaling concerns related to telomerase pathways

8. Half-Life

Epithalon is believed to have a relatively short circulating plasma half-life.

However, many of the compound’s proposed mechanisms involve downstream signaling effects that may persist substantially longer than the peptide itself.

9. Storage Information

  • Store refrigerated before and after reconstitution
  • Protect from direct light exposure
  • Avoid repeated freeze-thaw cycles
  • Maintain sterile handling practices during preparation

10. Contraindications / Warnings

  • Active cancer or cancer history
  • Pregnancy or breastfeeding
  • Severe endocrine disorders
  • Known hypersensitivity to peptide compounds

11. Research References

  • PubMed
  • NIH Publications
  • Longevity and telomerase research literature
  • Peer-reviewed circadian biology journals